NuCana Plc (NCNA)
1.00
-0.02
(-1.96%)
USD |
NASDAQ |
Oct 16, 13:28
NuCana SG&A Expense (TTM) : 7.064M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.064M |
| March 31, 2026 | 11.51M |
| December 31, 2025 | 10.74M |
| September 30, 2025 | 9.964M |
| June 30, 2025 | 9.843M |
| March 31, 2025 | 5.705M |
| December 31, 2024 | 6.366M |
| September 30, 2024 | 7.269M |
| June 30, 2024 | 7.244M |
| March 31, 2024 | 7.536M |
| December 31, 2023 | 7.534M |
| September 30, 2023 | 7.739M |
| June 30, 2023 | 8.015M |
| March 31, 2023 | 8.188M |
| December 31, 2022 | 9.072M |
| September 30, 2022 | 10.07M |
| June 30, 2022 | 11.19M |
| Date | Value |
|---|---|
| March 31, 2022 | 11.72M |
| December 31, 2021 | 11.73M |
| September 30, 2021 | 11.46M |
| June 30, 2021 | 10.78M |
| March 31, 2021 | 9.902M |
| December 31, 2020 | 9.056M |
| September 30, 2020 | 8.755M |
| June 30, 2020 | 8.048M |
| March 31, 2020 | 7.904M |
| December 31, 2019 | 7.602M |
| September 30, 2019 | 7.425M |
| June 30, 2019 | 6.918M |
| March 31, 2019 | 6.945M |
| December 31, 2018 | 6.918M |
| September 30, 2018 | 4.879M |
| June 30, 2018 | 3.632M |
| March 31, 2018 | 1.726M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Biodexa Pharmaceuticals Plc | 5.629M |
| Mereo BioPharma Group Plc | 19.44M |
| BioNTech SE | 833.57M |
| Silence Therapeutics Plc | 21.27M |
| Compass Pathways Plc | 68.79M |